Related Experiment Video

Updated: Aug 17, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

Barriers to detecting and treating hypercholesterolaemia in patients with ischaemic heart disease: primary care

James Hickling1, Stephen Rogers, Irwin Nazareth

  • 1Department of Primary Care and Population Sciences, Royal Free and University College Medical School, University College London. james.hickling@gp-F83063.nhs.uk

The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|July 12, 2005
PubMed

Insights

Effective treatment of high cholesterol (hypercholesterolaemia) in ischemic heart disease patients is crucial but often lacking. Key barriers include practice organization, guideline confusion, GP errors, poor communication, and patient reluctance.

Area of Science:

  • Cardiovascular Medicine
  • Primary Care Research
  • Health Services Research

Background:

  • Effective management of hypercholesterolaemia in patients with ischemic heart disease (IHD) significantly reduces vascular mortality and events.
  • A substantial number of IHD patients do not receive adequate hypercholesterolaemia treatment.
  • Suboptimal treatment highlights a critical gap in cardiovascular disease prevention and management.

Purpose of the Study:

  • To identify and rank the barriers to detecting and treating hypercholesterolaemia in IHD patients from the perspective of primary care teams.
  • To understand the challenges faced by general practice teams in managing hypercholesterolaemia within the IHD population.
  • To inform targeted interventions for improving lipid management in IHD.

Main Methods:

  • A qualitative study employing the nominal group technique was conducted.
  • Participants included general practice teams within the North Thames region of the Medical Research Council General Practice Research Framework.
  • Barriers were identified and ranked to determine their relative importance.

Main Results:

  • Fourteen distinct barriers to hypercholesterolaemia detection and treatment were identified.
  • Primary barriers included organizational issues within general practices, conflicting external guidelines, general practitioner (GP) errors, communication gaps between secondary and primary care, and patient medication adherence challenges.
  • These factors collectively impede effective lipid management in IHD patients.

Conclusions:

  • The suboptimal detection and treatment of hypercholesterolaemia in IHD patients stem from multifaceted issues operating at different levels.
  • Interventions aimed at improving hypercholesterolaemia management must comprehensively address identified barriers for successful implementation.
  • Addressing organizational, guideline, clinical, inter-professional, and patient-level factors is essential for enhancing cardiovascular care.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...